Many users report stronger appetite reduction within the first two weeks compared to semaglutide
Clin Chim Acta 2005;360:173-7
From a pharmacological perspective, these medications have no known pharmacokinetic interactions
That means the efficacy data, such as any body weight changes cited, are based on those protocols, not on microdosing approaches
MOTS-C improves glucose metabolism and insulin sensitivity, supporting healthy blood sugar regulation, metabolic flexibility, and reducing risk factors for metabolic syndrome and type 2 diabetes
You're not just treating one symptom you're supporting your body's fundamental processes for detoxification, cellular protection, and optimal function